Patent Assignment
Reel/Frame 040282/0873
Change of Address
Recorded: 2016-10-03
Pages: 5
Assignor
EGALET US, INC.
Executed: 2016-07-13
Assignee
EGALET US, INC.
600 LEE ROAD, SUITE 100, WAYNE, PENNSYLVANIA, 19087
Covered Properties
(18)
Therapeutic Compositions for Intranasal Administration Which Include Ketorolac
Patent:
6,333,044 →
Application:
08/383,707 →
Therapeutic Compositions for Intranasal Administration Which Include Ketorolac
Therapeutic Compositions for Intranasal Administration Which Include Ketorolac
Use of neurosteroids to treat neuropathic pain
Application:
11/177,977 →
Publication:
US 2006/0009432
Therapeutic Compositions for Intranasal Administration of Ketorolac
Application:
11/813,763 →
Publication:
US 2009/0042968
Device for Intranasal Administration
Unit Dose Formulations of Ketorolac for Intranasal Administration
Application:
12/483,586 →
Publication:
US 2010/0016402
Device for Intranasal Administration
Unit Dose Formulations of Ketorolac for Intranasal Administration
Application:
13/603,232 →
Publication:
US 2012/0329849
Device for Intranasal Administration
Application:
13/615,162 →
Publication:
US 2013/0000634
Stabilized Ketorolac Compositions
Application:
13/786,293 →
Publication:
US 2013/0274650
Device for Intranasal Administration of Ketorolac
Application:
13/791,780 →
Publication:
US 2013/0186391
Device for Intranasal Administration
Application:
14/590,824 →
Publication:
US 2015/0314084
Unit Dose Formulations of Ketorolac for Intranasal Administration
Application:
14/947,319 →
Publication:
US 2016/0136089
Therapeutic compositions for intranasal administration of ketorolac
Application:
60/639,022 →
Unit Dose Formulations of Ketorolac and Lidocaine Combination for Intranasal Administration
Application:
61/061,522 →
Unit Dose Formulations of Ketorolac for Intranasal Administration
Application:
61/160,254 →
Stabilized Ketorolac Compositions
Application:
61/625,611 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 3, 2012
From: LAWRENCE, RICHARD P.
To: LUITPOLD PHARMACEUTICALS, INC.
Reel/Frame 028723/0956 →
Assignment of Assignor's Interest
Oct 16, 2012
From: ROXRO PHARMA, INC.
To: LUITPOLD PHARMAEUTICALS, INC.
Reel/Frame 029139/0368 →
Assignment of Assignor's Interest
Oct 16, 2012
From: WHITING, ROGER; THIRUCOTE, RAMACHANDRAN
To: ROXRO PHARMA, INC.
Reel/Frame 029139/0295 →
Assignment of Assignor's Interest
Oct 24, 2012
From: ROXRO PHARMA, INC.
To: LUITPOLD PHARMACEUTICALS, INC.
Reel/Frame 029184/0527 →
Assignment of Assignor's Interest
Oct 24, 2012
From: WHITING, ROGER; THIRUCOTE, RAMACHANDRAN
To: ROXRO PHARMA, INC.
Reel/Frame 029184/0493 →
Assignment of Assignor's Interest
Oct 1, 2015
From: LUITPOLD PHARMACEUTICALS, INC.
To: EGALET US, INC.
Reel/Frame 036702/0474 →
Security Interest
Aug 31, 2016
From: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 039600/0791 →
Change of Name
Jul 11, 2019
From: EGALET US INC.
To: ZYLA LIFE SCIENCES US INC.
Reel/Frame 049736/0775 →
Release of Security Interest
Aug 5, 2020
From: U.S. BANK NATIONAL ASSOCIATION
To: ZYLA LIFE SCIENCES, F/K/A EGALET CORPORATION; ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC.; EGALET LIMITED
Reel/Frame 053411/0496 →
Change of Name
Jan 19, 2023
From: ZYLA LIFE SCIENCES US INC.
To: ZYLA LIFE SCIENCES US, LLC
Reel/Frame 062434/0818 →
Change of Name
Jan 19, 2023
From: ZYLA LIFE SCIENCES, INC.
To: ZYLA LIFE SCIENCES, LLC
Reel/Frame 062434/0955 →